Cidara Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits